Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Straub

Showing results (221-230 of 374) with videos related to

Pageof 38
Sort By:
Neurology. Clinical Practice|February 18, 2026
Assessing the Relationship of Quality of Life With Functional Status in a Large Cohort of Adult Patients With Neuromuscular DisordersKaren S W Wong, Anando Sen, Jassi Michell-Sodhi, et al.
Brain : a Journal of Neurology|May 8, 2007
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathiesHaiyan Zhou, Heinz Jungbluth, Caroline A Sewry, et al.
Brain : a Journal of Neurology|December 28, 2010
A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophyDebbie Hicks, Anna Sarkozy, Nuria Muelas, et al.
The Lancet. Neurology|September 12, 2014
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 studyThomas Voit, Haluk Topaloglu, Volker Straub, et al.
Neurology|October 31, 2014
Dystrophin quantification: Biological and translational research implicationsKaren Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, et al.
Journal of Neuromuscular Diseases|September 27, 2021
Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular DystrophyMargaret E Benny Klimek, Maria Candida Vila, Katie Edwards, et al.
Neurology|February 1, 2023
<i>DMD</i> Genotypes and Motor Function in Duchenne Muscular Dystrophy: A Multi-institution Meta-analysis With Implications for Clinical TrialsFrancesco Muntoni, James Signorovitch, Gautam Sajeev, et al.
Neuromuscular Disorders : NMD|March 9, 2010
Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutationsFatemeh Geranmayeh, Emma Clement, Lucy H Feng, et al.
Brain : a Journal of Neurology|November 22, 2011
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trialsKaren Anthony, Sebahattin Cirak, Silvia Torelli, et al.
Plos One|April 26, 2023
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophyVandana Ayyar Gupta, Jacqueline M Pitchforth, Joana Domingos, et al.
Pageof 38

Showing results (221-230 of 374) with videos related to

Sort By:
Pageof 38
Neurology. Clinical Practice|February 18, 2026
Assessing the Relationship of Quality of Life With Functional Status in a Large Cohort of Adult Patients With Neuromuscular DisordersKaren S W Wong, Anando Sen, Jassi Michell-Sodhi, et al.
Brain : a Journal of Neurology|May 8, 2007
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathiesHaiyan Zhou, Heinz Jungbluth, Caroline A Sewry, et al.
Brain : a Journal of Neurology|December 28, 2010
A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophyDebbie Hicks, Anna Sarkozy, Nuria Muelas, et al.
The Lancet. Neurology|September 12, 2014
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 studyThomas Voit, Haluk Topaloglu, Volker Straub, et al.
Neurology|October 31, 2014
Dystrophin quantification: Biological and translational research implicationsKaren Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, et al.
Journal of Neuromuscular Diseases|September 27, 2021
Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular DystrophyMargaret E Benny Klimek, Maria Candida Vila, Katie Edwards, et al.
Neurology|February 1, 2023
<i>DMD</i> Genotypes and Motor Function in Duchenne Muscular Dystrophy: A Multi-institution Meta-analysis With Implications for Clinical TrialsFrancesco Muntoni, James Signorovitch, Gautam Sajeev, et al.
Neuromuscular Disorders : NMD|March 9, 2010
Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutationsFatemeh Geranmayeh, Emma Clement, Lucy H Feng, et al.
Brain : a Journal of Neurology|November 22, 2011
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trialsKaren Anthony, Sebahattin Cirak, Silvia Torelli, et al.
Plos One|April 26, 2023
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophyVandana Ayyar Gupta, Jacqueline M Pitchforth, Joana Domingos, et al.
Pageof 38